[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-1-en-105":3,"doc-seo-239735-105":53,"doc-detail-239735-en":126},{"code":4,"msg":5,"data":6},0,"success",[7,14,19,24,29,34,39,44,49],{"id":8,"doc_module":9,"doc_module_name":10,"category_name":11,"show_sort_weight":12,"slug":13},11,1,"Template","Presentations",90,"presentations",{"id":15,"doc_module":9,"doc_module_name":10,"category_name":16,"show_sort_weight":17,"slug":18},12,"Resumes",80,"resumes",{"id":20,"doc_module":9,"doc_module_name":10,"category_name":21,"show_sort_weight":22,"slug":23},14,"Invoices",70,"invoices",{"id":25,"doc_module":9,"doc_module_name":10,"category_name":26,"show_sort_weight":27,"slug":28},15,"Posters",60,"posters",{"id":30,"doc_module":9,"doc_module_name":10,"category_name":31,"show_sort_weight":32,"slug":33},16,"Social Media",50,"social-media",{"id":35,"doc_module":9,"doc_module_name":10,"category_name":36,"show_sort_weight":37,"slug":38},17,"Forms",40,"forms",{"id":40,"doc_module":9,"doc_module_name":10,"category_name":41,"show_sort_weight":42,"slug":43},18,"Letters",30,"letters",{"id":45,"doc_module":9,"doc_module_name":10,"category_name":46,"show_sort_weight":47,"slug":48},21,"Paper Templates",5,"papers-templates",{"id":50,"doc_module":9,"doc_module_name":10,"category_name":51,"show_sort_weight":4,"slug":52},158,"General","general-158",{"code":4,"msg":54,"data":55},"ok",{"site_id":56,"language":57,"slug":58,"title":59,"keywords":60,"description":61,"schema_data":62,"social_meta":119,"head_meta":121,"extra_data":123,"updated_unix":125},105,"en","capa-dashboards-in-the-pharmaceutical-industry-an-implementation-guide","CAPA Dashboards in the Pharmaceutical Industry - An Implementation Guide","","CAPA Dashboards in the Pharmaceutical Industry provides a practical framework for monitoring Corrective and Preventive Action activities within pharmaceutical quality management. The guide explains CAPA as a regulated, closed-loop process linked to GMP expectations and continuous improvement, then shows how dashboards aggregate CAPA data into actionable KPIs. It supports managerial oversight for audit readiness, trend detection, resource and performance evaluation, and organization-wide accountability, aligning reporting with regulatory requirements such as FDA quality system expectations and related updates.",{"@graph":63,"@context":118},[64,80,101],{"@type":65,"itemListElement":66},"BreadcrumbList",[67,71,74,77],{"item":68,"name":69,"@type":70,"position":9},"https://docshare.wps.com","Home","ListItem",{"item":72,"name":10,"@type":70,"position":73},"https://docshare.wps.com/template/",2,{"item":75,"name":11,"@type":70,"position":76},"https://docshare.wps.com/template/presentations/",3,{"item":78,"name":59,"@type":70,"position":79},"https://docshare.wps.com/template/capa-dashboards-in-the-pharmaceutical-industry-an-implementation-guide/239735/",4,{"url":78,"name":59,"@type":81,"image":82,"author":87,"headline":59,"publisher":90,"fileFormat":93,"inLanguage":57,"description":61,"dateModified":94,"datePublished":95,"encodingFormat":93,"isAccessibleForFree":96,"interactionStatistic":97},"DigitalDocument",{"url":83,"@type":84,"width":85,"height":86},"https://docshare.wps.com/thumbnails/capa-dashboards-in-the-pharmaceutical-industry-an-implementation-guide/239735.png","ImageObject",442,249,{"name":88,"@type":89},"McGucket","Person",{"url":68,"name":91,"@type":92},"DocShare","Organization","application/pdf","2026-10-27","2026-09-11",true,{"@type":98,"interactionType":99,"userInteractionCount":25},"InteractionCounter",{"@type":100},"ViewAction",{"@type":102,"mainEntity":103},"FAQPage",[104,110,114],{"name":105,"@type":106,"acceptedAnswer":107},"What is CAPA in a pharmaceutical regulatory context?","Question",{"text":108,"@type":109},"CAPA is the systematic investigation of quality deviations and the implementation of corrective actions to fix issues while preventive actions stop recurrence. In highly regulated industries like pharma, CAPA is often mandated as part of GMP-related expectations.","Answer",{"name":111,"@type":106,"acceptedAnswer":112},"Why is a closed-loop CAPA process important for compliance?",{"text":113,"@type":109},"Regulatory agencies expect CAPA systems to collect and analyze quality information, identify unfavorable trends, investigate root causes, and implement effective actions. Dashboards help support this by monitoring effectiveness and progress toward resolution.",{"name":115,"@type":106,"acceptedAnswer":116},"How do CAPA dashboards help QA/QC and operations managers?",{"text":117,"@type":109},"Dashboards provide early warning and performance management by summarizing CAPA status, overdue items, and verification of effectiveness. They also reveal trends that guide continuous improvement and help assess workload, efficiency, and accountability across teams.","https://schema.org",{"og:url":78,"og:type":120,"og:title":59,"og:site_name":91,"og:description":61},"article",{"robots":122,"canonical":78},"index,follow",{"doc_id":124,"site_id":56},239735,1791730266,{"code":4,"msg":5,"data":127},{"doc_id":124,"user_id":128,"nickname":88,"user_avatar":129,"doc_module":9,"category_id":8,"category_name":11,"doc_title":59,"doc_description":61,"doc_content":130,"file_id":131,"file_url":132,"file_type":133,"file_size":134,"view_count":25,"is_deleted":4,"is_public":9,"is_downloadable":9,"audit_status":9,"page_count":30,"language":135,"language_code":57,"site_id":56,"html_lang":57,"table_of_contents":136,"faqs":137,"seo_title":138,"seo_description":61,"update_tm":139,"read_time":140},1236954412713,"https://us-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","CAPA Dashboards in the Pharmaceutical Industry: An Implementation Guide  \nBy Adrien Laurent , CEO at IntuitionLabs • 4/17/2025 • 50 min read  \ncapa corrective-and-preventive-actions pharmaceutical life-sciences quality-management  \nregulatory-compliance fda gmp dashboard power-bi tableau google-data-studio kpi  \ndata-visualization  \nquality-assurance  \n© 2026 [IntuitionLabs.ai-North America](IntuitionLabs.ai-North America)'s Leading AI Software Development Firm for Pharmaceutical & Biotech. All rights reserved.  \nPage 1 of 16  \nIntuitionLabs-AI Software for Pharma & Biotech  \nCAPA Dashboards in the Pharmaceutical Industry: An Implementation Guide  \n[Revised January 13, 2026]  \nCAPA Dashboards in the Pharmaceutical Industry: An Implementation Guide  \nIntroduction to CAPA in Pharma and Regulatory Context  \nCorrective and Preventive Action (CAPA) is a core process in pharmaceutical quality management. It refers to the systematic investigation of quality deviations or issues (nonconformities) and the implementation of corrective actions to fix those issues and preventive actions to stop recurrence. In highly regulated industries like pharma , CAPA systems are not just best practice – they are often mandated by regulators as part of Good Manufacturing Practice (GMP) requirements. International guidelines such as ICH Q10 (Pharmaceutical Quality System) explicitly recognize CAPA as a fundamental pillar of an effective quality system. This means pharmaceutical companies must have robust procedures to log problems , investigate root causes , take corrective/preventive steps , and verify the effectiveness of those steps.  \nRegulatory agencies expect a closed-loop CAPA process that feeds into continuous improvement. For example , the U.S. FDA’s quality system regulations (21 CFR Parts 210/211 for drugs and Part 820 for devices) emphasize that firms should collect and analyze information on quality issues , identify unfavorable trends , investigate root causes , and implement effective CAPAs (Corrective and Preventive Actions (CAPA) -FDA) . During FDA inspections , CAPA systems are a key focus area. In fact , CAPA deficiencies consistently appear in approximately 40–48% of Form 483 observations issued to pharmaceutical manufacturers , and CAPA has topped the list of most-cited FDA observations in the medical device industry since fiscal year 2010 (The role of CAPA in pharma) . This underscores that having a good CAPA process in place is not optional – it’s critical for compliance.  \nKey 2026 Regulatory Update: For medical device manufacturers , the FDA’s new Quality Management System Regulation (QMSR) takes effect on February 2, 2026 , harmonizing 21 CFR Part 820 with ISO 13485:2016 . This significant regulatory change streamlines quality system requirements and directly impacts CAPA procedures , design controls , and traceability requirements. Companies should ensure their CAPA dashboards and QMS processes are aligned with both traditional FDA requirements and the ISO 13485 framework (FDA QMSR Final Rule) .  \nGiven this context , the ability to monitor and report on CAPA activities is vital. Management needs visibility into how well the CAPA system is working: Are issues being addressed promptly? Are there recurring problems? Are we meeting internal and regulatory expectations for quality improvement? This is where a CAPA dashboard comes into play. A CAPA dashboard is a reporting interface (often part of an electronic QMS like Veeva Vault or business intelligence tool) that aggregates CAPA data into key metrics and visualizations for quick insight. By providing a real-time window into CAPA performance , dashboards help ensure the CAPA process remains effective , proactive , and in control of regulatory risk.  \nImportance of CAPA Dashboards for Managerial Reporting  \nFor managers in QA/QC or operations , a CAPA dashboard serves as an early-warning and performance management tool. Instead of sifting through individual CAPA reports or lengt","cbCaiim4xdJiufuo","https://ap.wps.com/l/cbCaiim4xdJiufuo","pdf",408001,"English","# Introduction to CAPA in Pharma and Regulatory Context\n## Corrective and Preventive Action as a core quality system process\n## Regulatory expectations and closed-loop monitoring\n## Why CAPA dashboards matter for management visibility\n# Importance of CAPA Dashboards for Managerial Reporting\n## Regulatory compliance and audit readiness\n## Continuous improvement through trend analysis\n## Resource and performance management\n## Accountability and engagement","[{\"question\":\"What is CAPA in a pharmaceutical regulatory context?\",\"answer\":\"CAPA is the systematic investigation of quality deviations and the implementation of corrective actions to fix issues while preventive actions stop recurrence. In highly regulated industries like pharma, CAPA is often mandated as part of GMP-related expectations.\"},{\"question\":\"Why is a closed-loop CAPA process important for compliance?\",\"answer\":\"Regulatory agencies expect CAPA systems to collect and analyze quality information, identify unfavorable trends, investigate root causes, and implement effective actions. Dashboards help support this by monitoring effectiveness and progress toward resolution.\"},{\"question\":\"How do CAPA dashboards help QA/QC and operations managers?\",\"answer\":\"Dashboards provide early warning and performance management by summarizing CAPA status, overdue items, and verification of effectiveness. They also reveal trends that guide continuous improvement and help assess workload, efficiency, and accountability across teams.\"}]","CAPA Dashboards in the Pharmaceutical Industry - An Implementation Guide | PDF",1789152476,6]